Evaluating a New Software (OTOGUIDE) to Help Monitor Electrode Insertion During Cochlear Implant Surgery. (OGUID)
Monitoring Electrode Insertion During Cochlear Implant Surgery With OTOGUIDE
Cochlear implants are a successful treatment for severe hearing loss in both children and adults. The procedure involves placing an electrode array into the cochlea to stimulate the auditory nerve, helping patients to hear. For the best results, it's crucial to place the electrode precisely and gently to avoid damaging delicate structures inside the ear. However, currently, surgeons lack feedback on the insertion status, making it difficult to confirm correct electrode positioning, especially regarding insertion depth, such as angle, frequency, or millimeters. New technologies are being developed to provide feedback during surgery, helping surgeons place the electrode more accurately. One such technology, recently developed by MED-EL, is called OTOGUIDE. This software offers immediate information on the electrode's position and functioning during the operation, aiming to improve surgical precision and hearing outcomes.
This clinical investigation aims to evaluate the performance and safety of OTOGUIDE, which assists surgeons during cochlear implant procedures by helping identify the position and angle of electrode contacts placed inside the cochlea. The primary objective is to confirm that OTOGUIDE can accurately detect which electrodes are inserted into the cochlea, with results that are more than 80% consistent with standard CT imaging (either during or after surgery). The secondary objective is to verify that OTOGUIDE can estimate the insertion angle of a specific electrode (C1) with a margin of error smaller than 60 degrees compared to CT imaging.
Participants who agree to take part and sign the informed consent form will undergo up to three study visit, which coincides with their scheduled routine cochlear implant surgery visits. During the Surgery Visit intraoperative measurements will be performed using both OTOGUIDE and the MAESTRO system. CT imaging (either during or after surgery, depending on routine clinical practice) will be used to verify the electrode array's position inside the cochlea.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Jasmine Rinnofner
- Número de teléfono: +43577881694
- Correo electrónico: jasmine.rinnofner@medel.com
Ubicaciones de estudio
-
-
Bavaria
-
Munich, Bavaria, Alemania, 81377
- Aún no reclutando
- Klinikum der Universität München, Campus Großhadern Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde
-
Contacto:
- Florian Simon, Dr.med.
- Número de teléfono: +49894400-81449
- Correo electrónico: florian.simon@med.uni-muenchen.de
-
-
-
-
Tyrol
-
Innsbruck, Tyrol, Austria, 6020
- Reclutamiento
- Medizinische Universität Innsbruck
-
Contacto:
- Joachim Schmutzhard, Prof. Dr. med.
- Número de teléfono: +43 512 504 23141
- Correo electrónico: Joachim.Schmutzhard@i-med.ac.at
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Minimum age of eighteen (18) years at time of enrolment.
- Subjects to be implanted with a compatible MED-EL cochlear implant (CI) (Mi1200 SYNCHRONY (PIN), Mi1210 SYNCHRONY ST, Mi1250 SYNCHRONY 2 (PIN), Mi1260 SONATA 2) according to clinical routine.
- Signed and dated informed consent before the start of any study-specific procedure.
Exclusion Criteria:
- Previously having received a CI on the ear to be tested (Re-implantation).
- Evidence of ossification or any other cochlear anomaly (e.g., malformation) that might prevent complete insertion of the electrode array or might cause increased risk of infection (e.g. dysplastic cochlear), as confirmed by medical examination and/or as per CT/MRI.
- Known absence of cochlear development or if the cause of deafness is non-functionality of the auditory nerve and/or the upper auditory pathway.
- Evidence of active external or middle ear infection or history of recurrent middle ear infection in the ear to be implanted.
- Acute cholesteatoma
- The tympanic membrane is perforated in the ear to be implanted.
- Pre-existing condition known to prohibit CT imaging before and after cochlear implantation.
- Women being pregnant or nursing.
- Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Otro: Monitoring electrode insertion with OTOGUIDE
Monitoring electrode insertion with OTOGUIDE during routine cochlear implantation
|
OTOGUIDE performs objective measurements to enable the monitoring of the electrode insertion and the functioning of the electrode.
OTOGUIDE guides the users through a workflow-based session to assess the implant status and to define a surgical approach.
The users can plan an insertion target and monitor the real-time electrode insertion using an impedance-based method to automatically detect the number of contacts inside the cochlea.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of inserted electrodes
Periodo de tiempo: through study completion, an average of 1 year
|
The primary endpoint is the agreement rate between OTOGUIDE and intra- or post-operative CT imaging in detecting which contacts in an electrode array are inserted and which are not inserted in the cochlea.
|
through study completion, an average of 1 year
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Insertion angle of C1 electrode contact
Periodo de tiempo: through study completion, an average of 1 year
|
The secondary endpoint is the deviation (i.e., the absolute difference) between the insertion angle for the C1 electrode contact estimated by OTOGUIDE and the insertion angle as assessed with intra- or post-operative CT imaging.
|
through study completion, an average of 1 year
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Deviation in Hz of the frequencies allocated to C1 - C12 electrode contacts
Periodo de tiempo: through study completion, an average of 1 year
|
Deviation in Hz of the frequencies allocated to C1 - C12 electrode contacts as estimated by OTOGUIDE and the allocated frequencies as assessed with CT imaging
|
through study completion, an average of 1 year
|
|
Deviation in degree of the insertion angles of C2 - C12 electrode contacts
Periodo de tiempo: through study completion, an average of 1 year
|
Deviation in degree of the insertion angles of C2 - C12 electrode contacts estimated by OTOGUIDE and the insertion angles as assessed with intra-or post-operative CT imaging
|
through study completion, an average of 1 year
|
|
Intra-operative impedance values
Periodo de tiempo: through study completion, an average of 1 year
|
Deviation in kΩ of the intra-operative impedance values derived from OTOGUIDE and MAESTRO
|
through study completion, an average of 1 year
|
|
Product-specific feedback
Periodo de tiempo: through study completion, an average of 1 year
|
OTOGUIDE usability and satisfaction questionnaire for clinicians
|
through study completion, an average of 1 year
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- MED-EL_CRD_2024_04
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .